Mo Ling Chen
Private Equity Investor bei Edmond De Rothschild Investment Partners (Shanghai) Ltd.
Profil
Ms. Mo Ling Chen is Partner at Edmond De Rothschild Investment Partners (Shanghai) Ltd.
Ms. Chen was previously employed as Senior Principal by BioVeda Investment Consulting.
Ms. Mo Ling Chen, has over 10 years science, business and investment experience in the Biotechnology and Pharmaceutical industries in Asia and Australasia.
She was previously with BioVeda Capital Singapore and involved in the funding of biotech ventures in US, Europe, Singapore and China, where she facilitated the Asian expansion plan of BioVeda’s portfolio companies in the region.
She was also involved with start-up companies in fund-raising and corporate strategy such as Asia Natural Products.
Prior to joining BioVeda Capital Singapore, Ms. Chen was the Australasian Territory Manager with Chiron Mimotopes, a world leader in Combinatorial Chemistry based in Melbourne Australia.
During her tenure there, she grew the Company’s business in the region by more than 50%.
Ms. Chen started her career with the Institute of Drug Technology, Australia (ASX:IDT) as an Analytical Chemist.
Born in Beijing, Ms. Chen holds a MBA from Monash Mt Eliza Business School and a Bachelor degree in Chemistry from Royal Melbourne Institute of Technology University in Melbourne.
Aktive Positionen von Mo Ling Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| Edmond De Rothschild Investment Partners (Shanghai) Ltd. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Mo Ling Chen
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
 Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Director of Investments | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Finance |
| Edmond De Rothschild Investment Partners (Shanghai) Ltd. | Finance |
